De Novo Transplant Disease
2 competing products in clinical development for De Novo Transplant Disease.
Pipeline by Phase
Approved2
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Tacrolimus targeted half-dose + Tacrolimus targeted plain dose | Astellas Pharma | Approved | UNKNOWN | 39 |
| Tacrolimus targeted half-dose + Tacrolimus targeted plain dose | Astellas Pharma | Approved | UNKNOWN | 39 |